Get startedLog in
    Picture of Atara Biotherapeutics logo

    ATRA — Atara Biotherapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Brief: Atara Biotherapeutics Provides Update On Clinical Programs For Ebvallo™ And Ata3219

    Picture of Atara Biotherapeutics logoAtara Biotherapeutics
    21/01/2025 12:45
    Jan 21 (Reuters) - Atara Biotherapeutics Inc  ATRA.O :
    * ATARA BIOTHERAPEUTICS PROVIDES UPDATE ON CLINICAL PROGRAMS
RELATED TO EBVALLO™ (TABELECLEUCEL) AND ATA3219
    * ATARA BIOTHERAPEUTICS INC: FDA HAS PLACED A CLINICAL HOLD
ON
ATARA'S ACTIVE INVESTIGATIONAL NEW DRUG (IND) APPLICATIONS
    * ATARA BIOTHERAPEUTICS INC: FDA ISSUES CLINICAL HOLD ON
EBVALLO™
(TABELECLEUCEL) AND ATA3219 STUDIES LINKED TO EBVALLO COMPLETE
RESPONSE LETTER
    * ATARA BIOTHERAPEUTICS INC: SCREENING AND ENROLLMENT OF NEW
PARTICIPANTS IN BOTH PROGRAMS HAVE BEEN PAUSED

Source text:  ID:nBw99pdYma 
Further company coverage:  ATRA.O

    Recent news on Atara Biotherapeutics

    See all news